Clinical trial

Adaptive Symptom Self-Management Immunotherapy Study

NCT05715255

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2023-05-08

PhaseNA

Study timeline

Study start (actual)2023-05-08Date precision: day

Registry last updated2026-07-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Colon Cancerunresolved

Lung Cancerunresolved

Skin Cancerunresolved

Rectum Cancerunresolved

Interventions

Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C)BEHAVIORAL

Active control comparatorBEHAVIORAL

Sponsors & collaborators

University of Arizonalead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

PhoenixArizona, United States1 Ann ArborMichigan, United States1 TucsonArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05715255 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.